Comments

Knight Therapeutics

KHTRFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$3.96

0.082.16%

At close: -

Knight Therapeutics (KHTRF) Forecast

News Earnings Knight Therapeutics (KHTRF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Knight Therapeutics (OTC:KHTRF) Stock Quotes, Forecast and News Summary

Knight Therapeutics Stock (OTC: KHTRF) stock price, news, charts, stock research, profile.

Open	$3.96
Close	$3.96
Volume / Avg.	1.02K / 6.19K
Day Range	$3.96 - $3.96
52 Wk Range	3.59 - 4.55
Market Cap	$391.11M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	201.81

Recent News

Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America

Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)

Akanksha Bakshi

Puma Biotech's Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer

Vandana Singh

Stocks That Hit 52-Week Lows On Wednesday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.7

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.96
Close	$3.96
Volume / Avg.	1.02K / 6.19K
Day Range	$3.96 - $3.96
52 Wk Range	3.59 - 4.55
Market Cap	$391.11M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	201.81

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Knight Therapeutics (KHTRF) stock?

You can purchase shares of Knight Therapeutics (OTCPK:KHTRF) through any online brokerage.

View our list of the best stock brokerages

Who are Knight Therapeutics (KHTRF) competitors?

There are no as such competitors for Knight Therapeutics.

What is the forecast, or price target, for Knight Therapeutics (KHTRF) stock?

Knight Therapeutics has a consensus price target of $7.50.

What is the current price for Knight Therapeutics (KHTRF)?

The stock price for Knight Therapeutics (OTCPK: KHTRF) is $ last updated .

Does Knight Therapeutics (KHTRF) pay a dividend?

There are no upcoming dividends for Knight Therapeutics.

When is Knight Therapeutics (OTCPK:KHTRF) reporting earnings?

Knight Therapeutics does not have any upcoming earnings scheduled.

Is Knight Therapeutics (KHTRF) going to split?

There is no upcoming split for Knight Therapeutics.